Increased vasopressin secretion from hypothalamic cultures following administration of exogenous vasopressin mRNA

Experimental Neurology

Volumn 141, Issue 2, 1996, Pages 165-172

  Mathiasen, Joanne R ^a   Maciejewski Lenoir, Dominique ^b   Bloom, Floyd E ^b   Sladek, Celia D ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FORSKOLIN; ISOBUTYLMETHYLXANTHINE; MESSENGER RNA; VASOPRESSIN;

ANIMAL CELL; ARTICLE; AUTORADIOGRAPHY; CELL CULTURE; CONTROLLED STUDY; FETUS; HYPOTHALAMUS; IMMUNOCYTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; VASOPRESSIN RELEASE;

EID: 0030272485     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1996.0150     Document Type: Article

References (15)

1. 1. AINGER, K., D. AVOSSA, F. MORGAN, S. J. HILL, C. BARRY, E. BARBARESE, AND J. H. CARSON. 1993. Transport and localization of exogenous myelin basic protein mRNA microinjected into oligodendrocytes. J. Cell Biol. 123: 431-441.
2. 2. DAVIS, L., G. A. BANKER, AND O. STEWARD. 1987. Selective dendritic transport of RNA in hippocampal neurons in culture. Nature 330: 477-479.
3. 3. DREIFUSS, J. J. 1975. A review on neurosecretory granules: Their contents and mechanisms of release. Ann. N.Y. Acad. Sci. 248: 184-201.
4. 4. JIRIKOWSKI, G. F., P. P. SANNA, AND F. E. BLOOM. 1990. mRNA coding for oxytocin is present in axons of the hypothalamoneurohypophysial tract. Proc. Natl. Acad. Sci. USA 87: 7400-7404.
5. 5. JIRIKOWSKI, G. F., P. P. SANNA, D. MACIEJEWSKI-LENOIR, AND F. E. BLOOM. 1992. Reversal of diabetes insipidus in Brattleboro rats: Intrahypothalamic injection of vasopressin mRNA. Science 255: 996-998.
6. 6. LEHMANN, E., J. HÄNZE, M. PAUSCHINGER, D. GANTEN, AND R. E. LANG. 1990. Vasopressin mRNA in the neurolobe of the rat pituitary. Neurosci. Lett. 111: 170-175.
7. 7. MACIEJEWSKI-LENOIR, D., G. F. JIRIKOWSKI, P. P. SANNA, AND F. E. BLOOM. 1993. Reduction of exogenous vasopressin RNA poly(A) tail length increases its effectiveness in transiently correcting diabetes insipidus in the Brattleboro rat. Proc. Natl. Acad. Sci. USA 90: 1435-1439.
8. 8. NEUMANN, I., AND Q. J. PITTMAN. 1994. An oxytocin (OXT) antisense oligonucleotide infused into the supraoptic nucleus rapidly alters the excitability of OXT neurons in lactating rats. Soc. Neurosci. Abstracts 20: 1538.
9. 9. NEUMANN, I., D. W. F. PORTER, R. LANDGRAF, AND Q. J. PITTMAN. 1994. Rapid effect on suckling of an oxytocin antisense oligonucleotide administered into rat supraoptic nucleus. Am. J. Physiol. 267: R852-R858.
10. 10. NOTTER, M. F. D., D. M. GASH, C. D. SLADEK, AND S. L. SCHAROUN. 1984. Vasopressin in reaggregated cell cultures of the developing hypothalamus. Brain Res. Bull. 12: 307-313.
11. 11. OEDING, P., K. SCHILLING, AND H. SCHMALE. 1990. Vasopressin expression in cultured neurons is stimulated by cyclic AMP. J. Neuroendocrinol. 2: 859-865.
12. 12. SLADEK, C. D., AND W. E. ARMSTRONG. 1987. GABA antagonists stimulate vasopressin release from organ-cultured hypothalamoneurohypophyseal explants. Endocrinology 120: 1576-1580.
13. 13. SLADEK, C. D., M. L. BLAIR, Y-H. CHEN, AND R. W. ROCKHOLD. 1986. Vasopressin and renin response to plasma volume loss in spontaneously hypertensive rats. Am. J. Physiol. 250: H443-H452.
14. 14. SLADEK, C. D., AND M. J. GALLAGHER. 1993. The stimulation of vasopressin gene expression in cultured hypothalamic neurons by cyclic adenosin 3′,5′-monophosphate is reversible. Endocrinology 133: 1320-1330.
15. 15. TREMBLEAU, A., M. MORALES, AND F. E. BLOOM. 1994. Aggregation of vasopressin mRNA in a subset of axonal swellings of the median eminence and posterior pituitary: Light and electron microscopic evidence. J. Neurosci. 14: 39-53.